Anuh Pharma has cleared the good manufacturing practice (GMP) milestone after undergoing an audit from the European Health regulator, the company informed in its filing with the stock exchanges. The European Directorate for the Quality of Medicines & HealthCare (EDQM) had conducted the audit at the bulk drug company’s manufacturing facilities located at Tarapur – 125 km from Mumbai, in India’s western state of Maharashtra. “We are pleased to inf…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.